Cover Image
Read Now

Sequencing of pharmacological management of Crohn's disease and ulcerative colitis a review of guidelines

This Rapid Response report aims to review the evidence-based guidelines associated with the early (first line) use of biologics in the sequencing of pharmacological treatments for patients with moderate to severe Crohn's disease and ulcerative colitis

Bibliographic Details
Main Authors: Ho, Chuong, Argáez, Charlene (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health January 31, 2019, 2019
Edition:Version 1.0
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Canada
Evidence-based Practice
Guidelines As Topic
Crohn Disease / Drug Therapy
Colitis, Ulcerative / Drug Therapy
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 01525nam a2200313 u 4500
001 EB001888658
003 EBX01000000000000001052019
005 00000000000000.0
007 tu|||||||||||||||||||||
008 200106 r ||| eng
100 1 |a Ho, Chuong 
245 0 0 |a Sequencing of pharmacological management of Crohn's disease and ulcerative colitis  |h Elektronische Ressource  |b a review of guidelines  |c Chuong Ho, Charlene Argáez 
250 |a Version 1.0 
260 |a Ottawa (ON)  |b Canadian Agency for Drugs and Technologies in Health  |c January 31, 2019, 2019 
300 |a 1 PDF file (11 pages)  |b illustration 
505 0 |a Includes bibliographical references 
653 |a Canada 
653 |a Evidence-Based Practice 
653 |a Guidelines as Topic 
653 |a Crohn Disease / drug therapy 
653 |a Colitis, Ulcerative / drug therapy 
700 1 |a Argáez, Charlene  |e [author] 
710 2 |a Canadian Agency for Drugs and Technologies in Health 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a CADTH rapid response report: summary with critical appraisal 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK541237  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a This Rapid Response report aims to review the evidence-based guidelines associated with the early (first line) use of biologics in the sequencing of pharmacological treatments for patients with moderate to severe Crohn's disease and ulcerative colitis 

Similar Items